HIV/AIDS

The Efavirenz-Emtricitabine-Tenofovir therapeutic combination in the modern clinical strategy of HIV treatment.

Crixivan is a popular medicine that is known as a protease inhibitor. It prescribed for the treatment of human immunodeficiency virus (HIV) infection. It slows the spread of HIV infection in the body. It is usually taken with other antiviral drugs. It will not work for viral infections or flu or colds.

P. carinii pneumonia is the most common life-threatening opportunistic infection in patients with AIDS. The taxonomy of the organism is unclear, having been classified as both protozoan and fungal.

The goal of antiretroviral therapy is to achieve the maximum suppression of HIV replication (HIV RNA level that is less than the lower limit of quantitation). Secondary goals include an increase in CD4 lymphocytes and an improved quality of life. The ultimate goal is decreased morbidity and mortality.